Imaging in lymphoma staging is most effectively performed with which modality combination?

Imaging in lymphoma staging is most effectively performed with which modality combination?

• A. CT and PET imaging
• B. Only X-ray
• C. Only MRI
• D. No imaging

Answer: (A)

Imaging for lymphoma staging benefits from having both metabolic and detailed anatomical information. PET with FDG shows areas of active lymphoma by highlighting increased glucose uptake, which often identifies disease that isn’t large enough to cause noticeable enlargement. CT provides precise anatomy and size measurements of lymph nodes and involved organs, letting you map exactly where the disease is and plan treatment. When these are combined into a PET-CT study, you get a comprehensive whole-body assessment: where disease is located and how metabolically active it is. This improves accuracy in staging, helps detect nodal and extranodal involvement, guides biopsy and radiation planning, and aids in monitoring response to therapy. The other options lack either metabolic information, whole-body coverage, or both, making them far less effective for lymphoma staging.

Imaging for lymphoma staging benefits from having both metabolic and detailed anatomical information. PET with FDG shows areas of active lymphoma by highlighting increased glucose uptake, which often identifies disease that isn’t large enough to cause noticeable enlargement. CT provides precise anatomy and size measurements of lymph nodes and involved organs, letting you map exactly where the disease is and plan treatment.

When these are combined into a PET-CT study, you get a comprehensive whole-body assessment: where disease is located and how metabolically active it is. This improves accuracy in staging, helps detect nodal and extranodal involvement, guides biopsy and radiation planning, and aids in monitoring response to therapy.

The other options lack either metabolic information, whole-body coverage, or both, making them far less effective for lymphoma staging.